1 Study Coverage

• 1.1 Ketorolac Product Introduction
• 1.2 Market Segments
• 1.3 Key Ketorolac Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Ketorolac Market Size Growth Rate by Type
  • 1.4.2 Tables
  • 1.4.3 Injection
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Ketorolac Market Size Growth Rate by Application
  • 1.5.2 Medical Uses
  • 1.5.3 Chemistry Uses
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Ketorolac Market Size, Estimates and Forecasts
  • 2.1.1 Global Ketorolac Revenue 2015-2026
  • 2.1.2 Global Ketorolac Sales 2015-2026
• 2.2 Global Ketorolac, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Ketorolac Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Ketorolac Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Ketorolac Competitor Landscape by Players

• 3.1 Ketorolac Sales by Manufacturers
  • 3.1.1 Ketorolac Sales by Manufacturers (2015-2020)
  • 3.1.2 Ketorolac Sales Market Share by Manufacturers (2015-2020)
• 3.2 Ketorolac Revenue by Manufacturers
  • 3.2.1 Ketorolac Revenue by Manufacturers (2015-2020)
  • 3.2.2 Ketorolac Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Ketorolac Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Ketorolac Revenue in 2019
  • 3.2.5 Global Ketorolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Ketorolac Price by Manufacturers
• 3.4 Ketorolac Manufacturing Base Distribution, Product Types
  • 3.4.1 Ketorolac Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Ketorolac Product Type
  • 3.4.3 Date of International Manufacturers Enter into Ketorolac Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Ketorolac Market Size by Type (2015-2020)
  • 4.1.1 Global Ketorolac Sales by Type (2015-2020)
  • 4.1.2 Global Ketorolac Revenue by Type (2015-2020)
  • 4.1.3 Ketorolac Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Ketorolac Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Ketorolac Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Ketorolac Revenue Forecast by Type (2021-2026)
  • 4.2.3 Ketorolac Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Ketorolac Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Ketorolac Market Size by Application (2015-2020)
  • 5.1.1 Global Ketorolac Sales by Application (2015-2020)
  • 5.1.2 Global Ketorolac Revenue by Application (2015-2020)
  • 5.1.3 Ketorolac Price by Application (2015-2020)
• 5.2 Ketorolac Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Ketorolac Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Ketorolac Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Ketorolac Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Ketorolac by Country
  • 6.1.1 North America Ketorolac Sales by Country
  • 6.1.2 North America Ketorolac Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Ketorolac Market Facts & Figures by Type
• 6.3 North America Ketorolac Market Facts & Figures by Application

7 Europe

• 7.1 Europe Ketorolac by Country
  • 7.1.1 Europe Ketorolac Sales by Country
  • 7.1.2 Europe Ketorolac Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Ketorolac Market Facts & Figures by Type
• 7.3 Europe Ketorolac Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Ketorolac by Region
  • 8.1.1 Asia Pacific Ketorolac Sales by Region
  • 8.1.2 Asia Pacific Ketorolac Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Ketorolac Market Facts & Figures by Type
• 8.3 Asia Pacific Ketorolac Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Ketorolac by Country
  • 9.1.1 Latin America Ketorolac Sales by Country
  • 9.1.2 Latin America Ketorolac Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Ketorolac Market Facts & Figures by Type
• 9.3 Central & South America Ketorolac Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Ketorolac by Country
  • 10.1.1 Middle East and Africa Ketorolac Sales by Country
  • 10.1.2 Middle East and Africa Ketorolac Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Ketorolac Market Facts & Figures by Type
• 10.3 Middle East and Africa Ketorolac Market Facts & Figures by Application

11 Company Profiles

• 11.1 Allergan
  • 11.1.1 Allergan Corporation Information
  • 11.1.2 Allergan Description and Business Overview
  • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Allergan Ketorolac Products Offered
  • 11.1.5 Allergan Related Developments
• 11.2 DeepCare Health
  • 11.2.1 DeepCare Health Corporation Information
  • 11.2.2 DeepCare Health Description and Business Overview
  • 11.2.3 DeepCare Health Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 DeepCare Health Ketorolac Products Offered
  • 11.2.5 DeepCare Health Related Developments
• 11.3 Cadila
  • 11.3.1 Cadila Corporation Information
  • 11.3.2 Cadila Description and Business Overview
  • 11.3.3 Cadila Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Cadila Ketorolac Products Offered
  • 11.3.5 Cadila Related Developments
• 11.4 FDC
  • 11.4.1 FDC Corporation Information
  • 11.4.2 FDC Description and Business Overview
  • 11.4.3 FDC Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 FDC Ketorolac Products Offered
  • 11.4.5 FDC Related Developments
• 11.5 Intas Laboratories
  • 11.5.1 Intas Laboratories Corporation Information
  • 11.5.2 Intas Laboratories Description and Business Overview
  • 11.5.3 Intas Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Intas Laboratories Ketorolac Products Offered
  • 11.5.5 Intas Laboratories Related Developments
• 11.6 Gufic Chem
  • 11.6.1 Gufic Chem Corporation Information
  • 11.6.2 Gufic Chem Description and Business Overview
  • 11.6.3 Gufic Chem Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Gufic Chem Ketorolac Products Offered
  • 11.6.5 Gufic Chem Related Developments
• 11.7 Ranbaxy
  • 11.7.1 Ranbaxy Corporation Information
  • 11.7.2 Ranbaxy Description and Business Overview
  • 11.7.3 Ranbaxy Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Ranbaxy Ketorolac Products Offered
  • 11.7.5 Ranbaxy Related Developments
• 11.8 Adley Formulation
  • 11.8.1 Adley Formulation Corporation Information
  • 11.8.2 Adley Formulation Description and Business Overview
  • 11.8.3 Adley Formulation Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Adley Formulation Ketorolac Products Offered
  • 11.8.5 Adley Formulation Related Developments
• 11.9 Neon Laboratories
  • 11.9.1 Neon Laboratories Corporation Information
  • 11.9.2 Neon Laboratories Description and Business Overview
  • 11.9.3 Neon Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Neon Laboratories Ketorolac Products Offered
  • 11.9.5 Neon Laboratories Related Developments
• 11.10 Sun Pharmaceutical Industries
  • 11.10.1 Sun Pharmaceutical Industries Corporation Information
  • 11.10.2 Sun Pharmaceutical Industries Description and Business Overview
  • 11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Sun Pharmaceutical Industries Ketorolac Products Offered
  • 11.10.5 Sun Pharmaceutical Industries Related Developments
• 11.1 Allergan
  • 11.1.1 Allergan Corporation Information
  • 11.1.2 Allergan Description and Business Overview
  • 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Allergan Ketorolac Products Offered
  • 11.1.5 Allergan Related Developments
• 11.12 Dallas Pharmaceuticals
  • 11.12.1 Dallas Pharmaceuticals Corporation Information
  • 11.12.2 Dallas Pharmaceuticals Description and Business Overview
  • 11.12.3 Dallas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Dallas Pharmaceuticals Products Offered
  • 11.12.5 Dallas Pharmaceuticals Related Developments
• 11.13 Nicholas Piramal India
  • 11.13.1 Nicholas Piramal India Corporation Information
  • 11.13.2 Nicholas Piramal India Description and Business Overview
  • 11.13.3 Nicholas Piramal India Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Nicholas Piramal India Products Offered
  • 11.13.5 Nicholas Piramal India Related Developments
• 11.14 AHPL
  • 11.14.1 AHPL Corporation Information
  • 11.14.2 AHPL Description and Business Overview
  • 11.14.3 AHPL Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 AHPL Products Offered
  • 11.14.5 AHPL Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Ketorolac Market Estimates and Projections by Region
  • 12.1.1 Global Ketorolac Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Ketorolac Revenue Forecast by Regions 2021-2026
• 12.2 North America Ketorolac Market Size Forecast (2021-2026)
  • 12.2.1 North America: Ketorolac Sales Forecast (2021-2026)
  • 12.2.2 North America: Ketorolac Revenue Forecast (2021-2026)
  • 12.2.3 North America: Ketorolac Market Size Forecast by Country (2021-2026)
• 12.3 Europe Ketorolac Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Ketorolac Sales Forecast (2021-2026)
  • 12.3.2 Europe: Ketorolac Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Ketorolac Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Ketorolac Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Ketorolac Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Ketorolac Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Ketorolac Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Ketorolac Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Ketorolac Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Ketorolac Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Ketorolac Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Ketorolac Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Ketorolac Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Ketorolac Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Ketorolac Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Ketorolac Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Ketorolac Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Ketorolac market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ketorolac market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Ketorolac market is segmented into
Tables
Injection
Other

Segment by Application, the Ketorolac market is segmented into
Medical Uses
Chemistry Uses
Other

Regional and Country-level Analysis
The Ketorolac market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ketorolac market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ketorolac Market Share Analysis
Ketorolac market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ketorolac business, the date to enter into the Ketorolac market, Ketorolac product introduction, recent developments, etc.

The major vendors covered:
Allergan
DeepCare Health
Cadila
FDC
Intas Laboratories
Gufic Chem
Ranbaxy
Adley Formulation
Neon Laboratories
Sun Pharmaceutical Industries
Cipla
Dallas Pharmaceuticals
Nicholas Piramal India
AHPL